Canakinumab reduces the risk of acute gouty arthritis flares during initiation of allopurinol treatment: results of a double-blind, randomised study (Q35012174)
scientific article published on May 3, 2011
Language:
(P31) (Q13442814)
(P50) (Q90000725)
(P304) 1264-1271
(P407) (Q1860)
(P433) 7
(P478) 70
(P577) Tuesday, May 3, 2011
(P921) (Q412486)
(P953) https://ard.bmj.com/content/annrheumdis/70/7/1264.full.pdf
https://europepmc.org/articles/PMC3103669
https://europepmc.org/articles/PMC3103669?pdf=render
https://syndication.highwire.org/content/doi/10.1136/ard.2010.144063
(P1433) (Q4767876)
(P1476) "Canakinumab reduces the risk of acute gouty arthritis flares during initiation of allopurinol treatment: results of a double-blind, randomised study" (language: en)
(P2093) Eduardo Mysler
Hsiao-Yi Lin
Marc De Meulemeester
Jozef Rovensky
Udayasankar Arulmani
Alison Balfour
Gerhard Krammer
Peter Sallstig
Alexander So
(P2860) (Q37779671)
(Q42412163)
(Q39284803)
(Q21195361)
(Q22305478)
(Q34984749)
(Q37492596)
(Q37294518)
(Q21195376)
(Q36790391)
(Q34755343)
(Q24675150)
(Q28131797)
(Q34563183)
(Q34562732)
(Q35522716)
(Q34400603)
(Q35555160)
(Q40504910)
(Q28335536)
(Q48917983)
(Q43263723)
(Q42456623)
(Q51870928)
(Q46271681)
(Q45167250)
(Q57528055)
(Q74374894)
(Q69357321)
(Q74580714)
(Q79116989)
(Q60704816)
other details
description scientific article published on May 3, 2011

External Links